New research from a major university’s press service highlights a potential link between myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS) and changes in the gut microbiome. The study, conducted with meticulous analyses and reported by the Columbia University press office, builds on a growing body of evidence suggesting that intestinal bacteria might influence the severity and progression of ME/CFS. This overview summarizes the key findings and what they mean for understanding the condition and future therapies.
In this investigation, researchers carried out comprehensive metagenomic and metabolomic analyses of stool samples from 106 individuals diagnosed with ME/CFS and 91 healthy controls. Metagenomics reveals the genetic potential of the gut microbiota, while metabolomics measures small molecules produced by microbial activity. Together, these approaches allowed scientists to compare not only which microbes were present but also how they functioned and interacted within the gut ecosystem. Remarkably, the study found clear differences in microbiome diversity, shifts in the abundance of specific bacterial groups, and distinctive patterns of microbial interactions between the ME/CFS group and healthy participants. Importantly, the researchers matched the two groups on key variables such as age, gender, place of residence, and socioeconomic status, aiming to isolate disease-related microbiome changes rather than demographic effects.
Among the microbial players, Faecalibacterium prausnitzii and Eubacterium rectale emerged as noteworthy. In healthy individuals, these bacteria are typically abundant and contribute positively to gut health. In contrast, people with ME/CFS showed reduced levels of Faecalibacterium prausnitzii and Eubacterium rectale, accompanied by impaired synthesis of butyric acid. Butyric acid serves as a crucial energy source for colon cells and plays a role in maintaining the gut barrier and regulating inflammation. The study also identified a lower level of C. butyricus, a bacterium involved in producing acetate, a key substrate for butyrate production. Surprisingly, Faecalibacterium prausnitzii was found to be increased in some ME/CFS samples, suggesting a complex and perhaps compensatory microbial response that warrants further investigation.
Beyond these particular species, the analysis revealed higher abundances of ten other bacterial taxa in ME/CFS patients. Some of these organisms have been linked in other conditions to fatigue or inflammatory processes. For instance, Bolteae has been associated with fatigue in multiple sclerosis research, while another organism, Ruminococcus gnavus, has been connected with inflammatory bowel disease in prior studies. These patterns point to a broader shift in the gut microbial community that could influence immune signaling, metabolic pathways, and energy balance in ME/CFS.
While the exact mechanisms connecting gut microbiota to ME/CFS remain to be fully elucidated, the authors emphasize that the findings offer a valuable foundation for developing targeted therapies. By identifying microbial signatures associated with ME/CFS, scientists can explore interventions that modulate the gut ecosystem. Potential directions include dietary strategies, prebiotic and probiotic approaches, and possibly precision microbiome therapies designed to restore beneficial functions such as butyrate production and barrier integrity. The research team stresses that translating these microbiome insights into effective treatments will require rigorous clinical testing, careful consideration of patient variability, and long-term safety evaluations. The overall aim is to reduce fatigue, improve physical function, and support better quality of life for individuals living with ME/CFS. It is hoped that a clearer understanding of the gut-brain axis in ME/CFS will unlock new, evidence-based options for management and care, guided by ongoing collaboration between clinicians, microbiologists, and patients themselves, as noted in the Columbia University press communication.
Related posts:
The goalscorers of Lionel Scaloni’s cycle in the Argentina national team Faecalibacterium prausnitzii and Depression: Probiotics in the Gut-Brain Axis The Gut-Brain Connection: How Microbes Influence Mood and Treatment The infant gut microbiome and maternal sources Alicante Futsal Clubs Stand Up to Valencian Federation Rules Gut Microbiome and Vitamin Production: Balancing Diet, Microbes, and Supplements Mediterranean diet with dairy boosts gut health and cardiometabolic markers Grapes and the Gut: How Daily Grapes May Shape the Microbiome Gut Microbes and the Daily Stress Response New Insights Into Gut Microbes, Eating Habits, and Obesity Metabolic Health, Gut Microbes, and Weight Loss: A Molecular Link (Summary) Gut Microbiome in Early Life Linked to Childhood Obesity Risk